Largest health care biotech companies by market cap
CRISPR Therapeutics has the lowest figure of the 24 health care biotech companies ranked by market value, at DKK 26.6B, followed by Adaptive Biotechnologies (DKK 31.4B) and Scholar Rock Holding (DKK 39.9B). Figures as of 19 Nov 2026, 00:13 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- CRISPR TherapeuticsDKK 26.6B
- Median
- DKK 72.4B
- Combined market value
- DKK 5.7T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Market cap ↑ | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|
| 1 | CRISPR TherapeuticsCRSP · Health Care | DKK 26.6B | DKK 273.75 | 0.10% up | 21% down | ||
| 2 | Adaptive BiotechnologiesADPT · Health Care | DKK 31.4B | DKK 193.85 | 0.11% down | 88% up | ||
| 3 | Scholar Rock HoldingSRRK · Health Care | DKK 39.9B | DKK 326.95 | 6.48% up | 14% up | ||
| 4 | Kodiak SciencesKOD · Health Care | DKK 43.6B | DKK 666.23 | 1.04% up | 396% up | ||
| 5 | ImmunovantIMVT · Health Care | DKK 46.8B | DKK 225.94 | 0.12% down | 43% up | ||
| 6 | ImmunityBioIBRX · Health Care | DKK 48.5B | DKK 45.64 | 7.03% up | 193% up | ||
| 7 | CG OncologyCGON · Health Care | DKK 48.7B | DKK 544.92 | 1.34% up | 85% up | ||
| 8 | Twist BioscienceTWST · Health Care | DKK 54B | DKK 792.51 | 3.88% up | 340% up | ||
| 9 | VaxcytePCVX · Health Care | DKK 63.1B | DKK 398.61 | 1.48% down | 22% up | ||
| 10 | Krystal BiotechKRYS · Health Care | DKK 63.7B | DKK 2,147.92 | 5.62% up | 46% up | ||
| 11 | QiagenQGEN · Health Care | DKK 69.7B | DKK 337.57 | 0.38% down | 12% up | ||
| 12 | Kymera TherapeuticsKYMR · Health Care | DKK 70.4B | DKK 825.07 | 0.32% down | 87% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | DKK 74.4B | DKK 652.54 | 0.18% down | 37% up | ||
| 14 | RepligenRGEN · Health Care | DKK 75.2B | DKK 1,176.13 | 6.47% up | 5% up | ||
| 15 | Bio-TechneTECH · Health Care | DKK 77.8B | DKK 495.53 | 0.17% up | 26% up | ||
| 16 | Neurocrine BiosciencesNBIX · Health Care | DKK 112.3B | DKK 1,109.31 | 1.84% down | 20% up | ||
| 17 | ExelixisEXEL · Health Care | DKK 113.5B | DKK 465.15 | 0.31% down | 63% up | ||
| 18 | BioNTechBNTX · Health Care | DKK 140.6B | DKK 567.12 | 1.89% down | 16% down | ||
| 19 | Revolution MedicinesRVMD · Health Care | DKK 235.5B | DKK 1,088.60 | 1.76% down | 131% up | ||
| 20 | BiogenBIIB · Health Care | DKK 253.1B | DKK 1,712.46 | 0.25% up | 49% up | ||
| 21 | argenxARGX · Health Care | DKK 403.2B | DKK 6,411.27 | 0.66% down | 4% up | ||
| 22 | ModernaMRNA · Health Care | DKK 542.4B | DKK 1,340.42 | 4.84% down | 755% up | ||
| 23 | Gilead SciencesGILD · Health Care | DKK 1.43T | DKK 1,151.00 | 0.75% down | 33% up | ||
| 24 | AmgenAMGN · Health Care | DKK 1.64T | DKK 3,023.53 | 3.07% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8114 DKK).
Questions and answers
Which health care biotech companies have the lowest market cap?
CRISPR Therapeutics (DKK 26.6B), Adaptive Biotechnologies (DKK 31.4B) and Scholar Rock Holding (DKK 39.9B) have the lowest market cap of the 24 health care biotech companies ranked here as of 19 Nov 2026, 00:13 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by market value.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by market value have a combined market value of DKK 5.7T as of 19 Nov 2026, 00:13 UTC.
What does ranking by market value measure?
What the stock market values the whole company at: its share price times the number of its shares.
Learn how this ranking works
All markets guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care biotech companies by market cap”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care
Underlying data: Yahoo Finance; SEC EDGAR.